tetano
Editor, Senior Moderator
Commun Dis Intell Q Rep. 2013 Dec 31;37(4):E398-406.
Flutracking weekly online community survey of influenza-like illness annual report 2011 and 2012.
Carlson SJ1, Dalton CB2, Butler MT1, Fejsa J3, Elvidge E4, Durrheim DN5.
Author information
Abstract
Flutracking is a national online community influenza-like illness (ILI) surveillance system that monitors weekly ILI activity and field vaccine effectiveness (FVE). This article reports on the 2011 and 2012 findings from Flutracking. There was a 22% increase in participants to 16,046 who completed at least one survey in 2012, compared with 2011 (13,101). By October 2012 (the end of the 2012 season), 54.2% of participants had received the 2012 seasonal vaccine, while by the end of the 2011 season, 55.9% of participants had received the 2011 seasonal vaccine. From 2007 to 2012 the FVE calculation for New South Wales participants demonstrated that the seasonal vaccine was effective except in 2009 when a novel H1N1 virus was dominant. The 2012 Flutracking ILI weekly incidence peaked in mid-July at 4.9% in the unvaccinated group, 1 month earlier than laboratory confirmed influenza. The 2011 Flutracking ILI weekly incidence peaked in mid-August at 4.1% in the unvaccinated group, 1 week later than laboratory confirmed influenza. Similar to laboratory notifications, there was an increase in ILI activity from 2010 to 2012, with the peak weekly ILI prevalence for 2012 Flutracking data, (unstratified by vaccination status), being higher (4.7%) than the peak weekly prevalence for 2011 (3.8%) and 2010 (3.7%). The 2012 Flutracking influenza season showed moderate levels of ILI, compared with lower levels of ILI seen in 2011 and 2010, and consistent with the increase in national influenza laboratory notifications.
This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from the Commonwealth. Requests and inquiries concerning reproduction and rights should be addressed to the Commonwealth Copyright Administration, Attorney General's Department, Robert Garran Offices, National Circuit, Barton ACT 2600 or posted at http://www.ag.gov.au/cca.
PMID:
24882237
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/24882237
Flutracking weekly online community survey of influenza-like illness annual report 2011 and 2012.
Carlson SJ1, Dalton CB2, Butler MT1, Fejsa J3, Elvidge E4, Durrheim DN5.
Author information
Abstract
Flutracking is a national online community influenza-like illness (ILI) surveillance system that monitors weekly ILI activity and field vaccine effectiveness (FVE). This article reports on the 2011 and 2012 findings from Flutracking. There was a 22% increase in participants to 16,046 who completed at least one survey in 2012, compared with 2011 (13,101). By October 2012 (the end of the 2012 season), 54.2% of participants had received the 2012 seasonal vaccine, while by the end of the 2011 season, 55.9% of participants had received the 2011 seasonal vaccine. From 2007 to 2012 the FVE calculation for New South Wales participants demonstrated that the seasonal vaccine was effective except in 2009 when a novel H1N1 virus was dominant. The 2012 Flutracking ILI weekly incidence peaked in mid-July at 4.9% in the unvaccinated group, 1 month earlier than laboratory confirmed influenza. The 2011 Flutracking ILI weekly incidence peaked in mid-August at 4.1% in the unvaccinated group, 1 week later than laboratory confirmed influenza. Similar to laboratory notifications, there was an increase in ILI activity from 2010 to 2012, with the peak weekly ILI prevalence for 2012 Flutracking data, (unstratified by vaccination status), being higher (4.7%) than the peak weekly prevalence for 2011 (3.8%) and 2010 (3.7%). The 2012 Flutracking influenza season showed moderate levels of ILI, compared with lower levels of ILI seen in 2011 and 2010, and consistent with the increase in national influenza laboratory notifications.
This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from the Commonwealth. Requests and inquiries concerning reproduction and rights should be addressed to the Commonwealth Copyright Administration, Attorney General's Department, Robert Garran Offices, National Circuit, Barton ACT 2600 or posted at http://www.ag.gov.au/cca.
PMID:
24882237
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/24882237